Metrics
- Price
- $15.95
- Market Cap $M
- N/A
- Rel Volume
- 1.79
- Vol Up 2W
- 44.40%
- Vol Trend 2W
- +8.30%
- 1D
- +4.59%
- 1W
- +14.42%
- 1M
- +46.20%
- 1M Slope
- +45.74%
- 6M Range
- 59.66%
- Score
- 72.5
- Sharp
- 8.6
Volume
Profile
Freenome develops blood-based cancer screening tests using AI and multiomics to detect disease earlier through minimally invasive diagnostics and precision medicine.
Healthcare
Biotech
Diagnostics
AI